AMNEAL PHARMACEUTICALS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Increase (Decrease) in Prepaid Expense and Other Assets of $24.15 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06
- AMNEAL PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $10.75M, a 13.13% increase year-over-year.
- AMNEAL PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $13.40M, a 2512.09% increase year-over-year.
- AMNEAL PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$1.01M.
- AMNEAL PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $10.16M.
- AMNEAL PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $19.16M, a 1898.23% increase from fiscal 2024.
- AMNEAL PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $959.00K.
- AMNEAL PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$37.81M.
- AMNEAL PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$9.88M, a 144.96% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $24.15M 10-Q · filed 2026-08-06 | $23.14M derived: sum of 3 quarters · filed 2026-08-06 | $33.30M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $13.40M 10-Q · filed 2026-05-07 | $12.39M derived: sum of 2 quarters · filed 2026-05-07 | $22.55M derived: sum of 3 quarters · filed 2026-05-07 | $32.05M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | -$1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $9.15M derived: sum of 2 quarters · filed 2026-02-27 | $18.65M derived: sum of 3 quarters · filed 2026-08-06 | $19.16M 10-K · filed 2026-02-27 | ||
| 2025-09-30 | $10.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $19.66M derived: sum of 2 quarters · filed 2026-08-06 | $20.17M 10-Q · filed 2025-11-06 | $19.05M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $9.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $10.02M 10-Q · filed 2026-08-06 | $8.89M derived: sum of 3 quarters · filed 2026-08-06 | $2.56M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $513.00K 10-Q · filed 2026-05-07 | -$610.00K derived: sum of 2 quarters · filed 2026-05-07 | -$6.95M derived: sum of 3 quarters · filed 2026-05-07 | -$10.24M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$7.46M derived: sum of 2 quarters · filed 2026-02-27 | -$10.75M derived: sum of 3 quarters · filed 2026-02-27 | $959.00K 10-K · filed 2026-02-27 | ||
| 2024-09-30 | -$6.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$9.63M derived: sum of 2 quarters · filed 2025-11-06 | $2.08M 10-Q · filed 2025-11-06 | -$10.92M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-06-30 | -$3.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $8.42M 10-Q · filed 2025-08-07 | -$4.59M derived: sum of 3 quarters · filed 2026-02-27 | $2.50M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-03-31 | $11.71M 10-Q · filed 2025-05-07 | -$1.30M derived: sum of 2 quarters · filed 2026-02-27 | $5.79M derived: sum of 3 quarters · filed 2026-02-27 | $3.05M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2023-12-31 | -$13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$5.92M derived: sum of 2 quarters · filed 2026-02-27 | -$8.65M derived: sum of 3 quarters · filed 2026-02-27 | -$37.81M 10-K · filed 2026-02-27 | ||
| 2023-09-30 | $7.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $4.35M derived: sum of 2 quarters · filed 2024-11-12 | -$24.81M 10-Q · filed 2024-11-12 | -$69.07M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-06-30 | -$2.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$31.90M 10-Q · filed 2024-08-09 | -$76.16M derived: sum of 3 quarters · filed 2025-02-28 | -$161.53M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-03-31 | -$29.16M 10-Q · filed 2024-05-08 | -$73.42M derived: sum of 2 quarters · filed 2025-02-28 | -$158.79M derived: sum of 3 quarters · filed 2025-02-28 | -$43.47M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2022-12-31 | -$44.26M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$129.63M derived: sum of 2 quarters · filed 2025-02-28 | -$14.30M derived: sum of 3 quarters · filed 2025-02-28 | -$9.88M 10-K · filed 2025-02-28 | ||
| 2022-09-30 | -$85.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $29.96M derived: sum of 2 quarters · filed 2023-11-09 | $34.38M 10-Q · filed 2023-11-09 | $28.87M derived: sum of 4 quarters · filed 2024-03-14 | ||
| 2022-06-30 | $115.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $119.75M 10-Q · filed 2023-08-08 | $114.23M derived: sum of 3 quarters · filed 2024-03-14 | $117.74M derived: sum of 4 quarters · filed 2024-03-14 | ||
| 2022-03-31 | $4.42M 10-Q · filed 2023-05-09 | -$1.09M derived: sum of 2 quarters · filed 2024-03-14 | $2.42M derived: sum of 3 quarters · filed 2024-03-14 | $27.01M derived: sum of 4 quarters · filed 2024-03-14 | ||
| 2021-12-31 | -$5.51M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$2.01M derived: sum of 2 quarters · filed 2024-03-14 | $22.58M derived: sum of 3 quarters · filed 2024-03-14 | $21.98M 10-K · filed 2024-03-14 | ||
| 2021-09-30 | $3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $28.09M derived: sum of 2 quarters · filed 2022-11-07 | $27.49M 10-Q · filed 2022-11-07 | $11.82M derived: sum of 4 quarters · filed 2023-03-03 | ||
| 2021-06-30 | $24.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $23.99M 10-Q · filed 2022-08-08 | $8.31M derived: sum of 3 quarters · filed 2023-03-03 | -$552.00K derived: sum of 4 quarters · filed 2023-03-03 | ||
| 2021-03-31 | -$602.00K 10-Q · filed 2022-05-06 | -$16.28M derived: sum of 2 quarters · filed 2023-03-03 | -$25.14M derived: sum of 3 quarters · filed 2023-03-03 | -$60.30M derived: sum of 4 quarters · filed 2023-03-03 | ||
| 2020-12-31 | -$15.67M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | -$24.54M derived: sum of 2 quarters · filed 2023-03-03 | -$59.70M derived: sum of 3 quarters · filed 2023-03-03 | -$33.31M 10-K · filed 2023-03-03 | ||
| 2020-09-30 | -$8.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$44.02M derived: sum of 2 quarters · filed 2021-11-08 | -$17.64M 10-Q · filed 2021-11-08 | -$15.25M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | -$35.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$8.77M 10-Q · filed 2021-08-09 | -$6.39M derived: sum of 3 quarters · filed 2022-03-01 | -$19.03M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $26.38M 10-Q · filed 2021-05-07 | $28.77M derived: sum of 2 quarters · filed 2022-03-01 | $16.13M derived: sum of 3 quarters · filed 2022-03-01 | $10.17M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$10.26M derived: sum of 2 quarters · filed 2022-03-01 | -$16.21M derived: sum of 3 quarters · filed 2022-03-01 | -$38.87M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | -$12.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$18.60M derived: sum of 2 quarters · filed 2020-11-06 | -$41.26M 10-Q · filed 2020-11-06 | -$40.23M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | -$5.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$28.61M 10-Q · filed 2020-08-06 | -$27.59M derived: sum of 3 quarters · filed 2021-03-01 | -$42.50M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-31 | -$22.66M 10-Q · filed 2020-05-11 | -$21.63M derived: sum of 2 quarters · filed 2021-03-01 | -$36.54M derived: sum of 3 quarters · filed 2021-03-01 | -$29.94M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$13.88M derived: sum of 2 quarters · filed 2021-03-01 | -$7.28M derived: sum of 3 quarters · filed 2021-03-01 | -$8.78M 10-K · filed 2021-03-01 | -$19.20M 10-K · filed 2019-03-01 | |
| 2018-09-30 | -$14.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$8.31M derived: sum of 2 quarters · filed 2019-11-07 | -$9.80M 10-Q · filed 2019-11-07 | -$3.10M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-06-30 | $6.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $5.11M 10-Q · filed 2019-08-05 | -$711.00K 10-Q · filed 2018-08-09 | $11.81M derived: sum of 3 quarters · filed 2020-03-02 | $24.46M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | -$1.49M 10-Q · filed 2019-05-09 | $5.21M derived: sum of 2 quarters · filed 2020-03-02 | $17.86M derived: sum of 3 quarters · filed 2020-03-02 | |||
| 2017-12-31 | $6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $19.35M derived: sum of 2 quarters · filed 2020-03-02 | $25.30M 10-K · filed 2020-03-02 | |||
| 2017-09-30 | $12.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $18.60M 10-Q · filed 2018-11-07 | ||||
| 2017-06-30 | $5.96M 10-Q · filed 2018-08-09 | |||||
| 2016-12-31 | -$2.04M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |